Track topics on Twitter Track topics that are important to you
The post Azitra secures $2.15 million convertible debt financing led jointly by Bios Partners and Connecticut Innovations appeared first on SynBioBeta.
The post News Digest #227 – Meet Azitra and the skin microbiome. Newco A-Alpha Bio, Lygos’ $15.5M and Inscripta’s new patents appeared first on SynBioBeta.
Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: AZITRA SECURES $2.15 MILLION CON...
Azitra Inc. today announced that it has secured $2.15 million in convertible debt financing to support advancement of the company’s pipeline of dermatology and skin care product...
Azitra, Inc. is a preclinical company that aims to harness the power of the microbiome on the skin. Since 2014, the company has been working with world-leading scientists in derma...
We have published hundreds of Azitra Inc. news stories on BioPortfolio along with dozens of Azitra Inc. Clinical Trials and PubMed Articles about Azitra Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Azitra Inc. Companies in our database. You can also find out about relevant Azitra Inc. Drugs and Medications on this site too.